EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 10 filers reported holding EYEGATE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $54,000 | -88.6% | 46,378 | -86.6% | 0.00% | -87.1% |
| Q2 2017 | $473,000 | +50.6% | 345,524 | +79.3% | 0.03% | +72.2% |
| Q4 2016 | $314,000 | -62.4% | 192,721 | -62.1% | 0.02% | -41.9% |
| Q3 2016 | $834,000 | -16.8% | 508,598 | +31.4% | 0.03% | -40.4% |
| Q2 2016 | $1,002,000 | +60.6% | 386,940 | +70.0% | 0.05% | +52.9% |
| Q4 2015 | $624,000 | -10.2% | 227,660 | -6.6% | 0.03% | +17.2% |
| Q3 2015 | $695,000 | – | 243,790 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 16,802,500 | $5,209,000 | 0.31% |
| WEDBUSH SECURITIES INC | 20,000 | $6,000 | 0.00% |
| US BANCORP \DE\ | 40,650 | $13,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 100 | $0 | 0.00% |
| NORTHERN TRUST CORP | 14,553 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 44,270 | $14,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 107,430 | $33,000 | 0.00% |
| MORGAN STANLEY | 5,000 | $2,000 | 0.00% |
| Invesco Ltd. | 10,323 | $3,000 | 0.00% |